Biogen (BIIB) Receivables - Net (2009 - 2026)

Biogen's Receivables - Net history runs 18 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 99.71% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 99.71% YoY), while the FY2025 annual figure was $4.4 million, down 42.11% from the prior year.
• Receivables - Net was $4.7 million for Q1 2026 at Biogen, up from $4.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.7 billion in Q4 2022 to a low of $4.4 million in Q4 2025.
• Historically, Receivables - Net has averaged $852.7 million across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2025 and 2026: Receivables - Net jumped 8564.32% in 2025, then slumped 99.71% in 2026.
• A 5-year view of Receivables - Net shows it stood at $1.7 billion in 2022, then dropped by 2.4% to $1.7 billion in 2023, then retreated by 15.58% to $1.4 billion in 2024, then sank by 99.69% to $4.4 million in 2025, then increased by 6.82% to $4.7 million in 2026.
• The last three Receivables - Net figures came in at $4.7 million (Q1 2026), $4.4 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.